Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TCS Holding will change its name to T-Technologies

10/16/24 TCSG

X5 Group revenue increased by 25%

10/16/24 FIVE

Genetico shareholders approved the additional share issue

10/16/24 GECO

GEH obtained control over TGK-2

10/16/24 TGKB

Nefaz reported for 9 months of 2024 by RAS

10/15/24 NFAZ

Board of Directors of Avangard Bank recommended dividends

10/15/24 AVAN

Flip collected a round early

10/15/24 OTCI

Moscow Exchange launches platinum and palladium trading

10/15/24 MOEX

Kristall increased the share of LWI in sales

10/15/24 KLVZ

MGKL is updating its image

10/15/24 MGKL